ETF Analytics
ETF Analytics
IndexUniverse.com

Data Query

BBH
Market Vectors Biotech

NAV & Price Overview (As of 06/18/2013)

Net Asset Value: Change: Change:
USD 69.48
USD 0.99
1.42%
Price Change: Change:
USD 69.46
USD 1.01
1.45%

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include small- and medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Holdings

Top 10 Holdings
Amgen Inc
14.00%
Gilead Sciences Inc
13.52%
Biogen Idec Inc
9.06%
Celgene Corporation
8.74%
Vertex Pharmaceuticals
6.25%
Regeneron Pharmaceuticals, Inc.
5.47%
Life Technologies Corp
4.94%
Alexion Pharmaceuticals, Inc.
4.64%
Illumina, Inc.
4.35%
Biomarin Pharmaceutical, Inc.
4.19%
Weighting
75.18%
As of 04/30/2013


Holdings - Country Allocation
Download Adobe Flash Player to view this page
Get Adobe Flash player
Holdings - Sector Breakdowns
Download Adobe Flash Player to view this page
Get Adobe Flash player

Historical NAV Performance (%)

1-Day
1-Week
1-Mo
3-Mo
YTD
1-Yr
1.42
-0.93
3.07
21.15
34.49
59.16
Cumulative
2012
2011
2010
2009
3 Yr*
5 Yr*
47.36
N/A
N/A
N/A
N/A
N/A
Annual/Annualized

Portfolio & Management

Fundamentals
Mean Market Cap:
20,160.38
P/E Ratio:
28.25
P/B Ratio:
6.14
Dividend Yield (% p.a):
0.02
30 Day SEC Yield:
-0.11
Dividend Frequency:
Annually
Portfolio Characteristics
Assets Under Management:
327,063,357
Exp Ratio:
0.35
Number of Holdings:
26
Management
Issuing Company:
Market Vectors
Inc Date:
2011-12-20
Trading Symbols:
BBH
Trading & Liquidity

The content on IndexUniverse.com and related sites is for informational purposes only. It is not designed to be used by investors in making specific investment decisions. The content is not intended as advice or recommendation.

© 2013 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.